GlassScriptPhysician profile
Troy A Sukhu
NPI 1508276734
$11,190.68
in general payments reported to CMS, 2019-2025
40 companies · $1,967 in 2025
The $1,967 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $194 · 2021: $711 · 2022: $659 · 2023: $1,775 · 2024: $4,993 · 2025: $1,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,240 · Consulting Fee: $3,545 · Travel and Lodging: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,239.58 |
| Consulting Fee | $3,545.00 |
| Travel and Lodging | $949.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,180.55 | 2022-2025 | Erleada |
| Boston Scientific Corporation | $1,558.21 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Ams 800 Artificial Urinary Sphincter |
| Astellas Pharma US INC | $786.81 | 2020-2025 | Xtandi, Veozah, Myrbetriq |
| Neotract INC. | $777.89 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $355.49 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $291.52 | 2019-2025 | Provenge |
| Bard Access Systems, INC. | $275.00 | 2023 | |
| Dornier Medtech America, INC | $259.26 | 2023 | Dornier Medtech |
| Urovant Sciences INC | $254.47 | 2021-2022 | |
| Endo USA, INC. | $242.22 | 2024-2025 | Xiaflex, Aveed, Edex |
| Telix Pharmaceuticals | $231.60 | 2023-2025 | Illuccix |
| Baxter Healthcare | $231.14 | 2023-2024 | Perclot, Tisseel |
| Ferring Pharmaceuticals INC. | $218.00 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $208.11 | 2022-2025 | Jelmyto |
| Teleflex LLC | $181.65 | 2021-2024 | Urolift |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $138.79 | 2022 | |
| Immunitybio, INC. | $132.28 | 2025 | |
| Tolmar, INC. | $109.14 | 2023-2025 | Eligard, Jatenzo |
| Abbvie INC. | $109.01 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.23 | 2023-2025 | |
| Coloplast Corp | $67.65 | 2023 | Titan |
| Philips North America LLC | $50.21 | 2025 | Disease Management Solutions Equipment Undivided |
| Innovation Technologies INC | $48.46 | 2022 | |
| Olympus America INC. | $45.56 | 2023-2025 | Itind System, Tecoflex |
| Myovant Sciences INC. | $38.33 | 2022 | |
| Endo Pharmaceuticals INC. | $37.07 | 2019-2024 | Aveed, Xiaflex |
| Antares Pharma, INC. | $36.07 | 2021-2024 | Tlando, Xyosted |
| Axonics, INC. | $26.19 | 2022 | |
| 180 Medical, INC. | $24.72 | 2021 | |
| Accord Healthcare, INC. | $21.79 | 2023 | |
| Halozyme INC | $21.59 | 2023 | |
| Blue Earth Diagnostics | $21.19 | 2021 | |
| Medtronic, INC. | $17.93 | 2025 | Interstim |
| Merck Sharp & Dohme LLC | $17.61 | 2024 | Keytruda |
| Sun Pharmaceutical Industries INC. | $17.34 | 2024 | |
| Hollister Incorporated | $17.26 | 2023 | Vapro, Infyna Chic |
| Calyxo, INC. | $17.06 | 2025 | Cvac Aspiration System |
| Shire North American Group INC | $16.99 | 2019 | |
| Zyla Life Sciences, INC. | $15.22 | 2020 | |
| Sagent Pharmaceuticals | $14.07 | 2023 | Glydo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Sukhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.